Resource Filter: Year
Development and optimization of a broad hyperplex immunofuorescence assay for tumor immune microenvironment characterization
Date
Profiling Cytokeratins in the Tumor Microenvironment Using Multiplex Immunofluorescence
Date
Immune Landscape of Adenoid Cystic Carcinoma using Multiplex Immunofluorescence and Digital Pathology
Date
A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides
Date
Optimal Antitumor Immunity is Triggered by WTX-124, a Clinical Stage Conditionally Activated INDUKINE™ Molecule that Releases Fully Potent IL-2 into the Tumor Microenvironment
Date
Development of WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule for the Treatment of Cancer
Date
The Combination of ACT and INDUKINE™ Therapy Leads to Improved Antitumor Immunity in Mouse Solid Tumors
Date
Spatial Analysis of Tumor Infiltrating Lymphocyte Populations in Syngeneic Mouse Tumor Models After Treatment with IL-12 (mWTX-330) or IL-2 (WTX-124) INDUKINE™ Molecules
Date
Fully Automated Sequential Immunofluorescence (seqIF) for Hyperplex Spatial Proteomics
Date
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas
Date